Summary
The presence and distribution of different neural markers in 30 neuroblastic tumours (neuroblastomas, ganglioneuroblastomas) and 6 non-neuroblastic tumours were investigated by immunocytochemistry. Neuron-specific enolase (NSE), S-100 protein, tyrosine hydroxylase, neurofilaments and glial fibrillary acidic protein (GFAP) were localized in 3 undifferentiated neuroblastic tumours (group A), 12 poorly differentiated tumours (group B) and 15 well differentiated neuroblastic tumours (group C). Non-neuroblastic tumours (3 lymphomas and 3 Ewing sarcomas) showed no immunoreactivity.
Tyrosine hydroxylase and, in particular, NSE were found in mature ganglion cells and developing neuroblasts of poorly and well differentiated tumours (groups B and C). S-100 was localised in neuroblasts with slender cytoplasmic processes in the same groups. Neurofilaments were detected in ganglion cells and differentiated neuroblasts (groups B and C) while GFAP was localised in immature neuroblasts of undifferentiated and poorly differentiated tumours (groups A and B). Thus, there are differences in the neural proteins found in neuroblastic tumours and a wide panel of antibodies against neural markers may be a useful tool in the histological assessment of nervous system neoplasms.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bignami A, Eng FL, Dahl D, Uyeda CT (1972) Localization of the glial fibrillary acid protein in astrocytes by immunofluorescence. Brain Res 28:351–354
Bradshaw RA, Schneider DM (1980) Proteins of the nervous system. 2nd Ed. Raven Press, New York
Ceccamea A, Bonamico M, Napoleoni M (1981) Criteri istologici per la valutazione prognostica del neuroblastoma. Tumori 67:605–612
Cocchia D, Michetti F (1981) S-100 antigen in satellite cells of the adrenal medulla and the superior cervical ganglion of the cat. An immunochemical and immunocytochemical study. Cell Tissue Res 215:103–112
Cushing H, Wohlbach SB (1927) The transformation of a malignant paravertebral sympathicoblastoma into a benign ganglioneuroma. Am J Pathol 3:203–216
Dahl D, Bignami A (1976) Immunogenic properties of the glial fibrillary acidic protein. Brain Res 116:150–157
Dahl D, Bignami A (1977) Preparation of antisera to neurofilament protein from chicken brain and human sciatic nerve. J Comp Neurol 176:645–658
Dahl D, Sellcoe DJ, Pero RT, Bignami A (1982) Immunostaining of neurofibrillary tangles in Alzheimer's senile dementia with a neurofilament antiserum. J Neurosci 2:113–119
Ferri GL, Probert, L, Cocchia D, Michetti F, Marangos PJ, Polak JM (1982) Evidence for the presence of S-100 protein in the glial component of the human enteric nervous system. Nature 297:409–410
Fox F, Davidson J, Thomas LB (1959) Maturation of sympathicoblastoma into ganglioneuroma. Report of two patients with 20 and 46 year survivals respectively. Cancer 12:108–116
Goldman JE, Schaumburg HH, Norton WT (1978) Isolation and characterisation of glial filaments from human brain. J Cell Biol 78:426–440
Huang WM, Gibson SJ, Facer P, Gu J, Polak JM (1983) Improved section adhesion for immunocytochemistry using high molecular weight polymers of L-lysine as a slide coating. Histochemistry 77:275–279
Hughes M, Marsden HB, Palmer MK (1974) Histologic patterns of neuroblastoma related to prognosis and clinical staging. Cancer 34:1706–1711
Huneeus FC, Davison PF (1970) Fibrillary proteins from squid axons. I. Neurofilament protein. J Mol Biol 52:415–428
Jessen KR, Mirsky R (1980) Glial cells in the enteric nervous system contain glial fibrillary acidic protein. Nature 286:736–737
Kahn HJ, Marks A, Thom H, Baumal R (1982) Role of antibody to S-100 protein in diagnostic pathology. Am J Clin Pathol 79 (3); 341–347
Kluck P, Van Muijen GNP, Van der Kamp WM, Tibboel D, Van Hoorn WA, Warnaar SO, Molenaar JC (1984) Hirschsprung's disease studied with monoclonal antineurofilament antibodies on tissue sections. Lancet I:652–653
Lennert K (1978) Classification of non Hodgkin's Lymphomas. In: Lennert K. et al.: Malignant lymphomas other than Hodgkin disease. Histology, cytology, ultrastructure, immunology. Springer, Berlin Heidelberg New York pt. 3, pp 83–110
Makinen J (1972) Microscopic patterns as a guide to prognosis of neuroblastoma in childhood. Cancer 29:1637–1646
Marangos PJ, Zis AP, Clark RL, Goodwin FK (1978) Neuronal, non-neuronal and hybrid forms of enolase in brain: structural, immunological and functional comparisons. Brain Res 150:117–133
Marangos PJ, Polak JM, Pearse AGE (1982) Neuron-specific enolase, a probe for peptidesecreting cells of the diffuse neuroendocrine system. In: Bloom SR, Polak JM, Lindenlaub E (eds) The systemic role of regulatory peptides. Symposium Oosterbeck Netherlands, May 2–6 1982. Symposia Medical Hoechst 18. FK Schattauer Verlag, Suuttgart New York
Moore BW (1965) A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 19:739–744
Nakajima T, Kameya T, Watanabe S, Hirota T, Sato Y, Shimosato Y (1982) An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues. Am J Surg Pathol 6:715–727
Osborn M, Weber K (1983) Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab Invest 48 (4):372–394
Pearse AGE (1968) Common cytochemical and ultrastructural characteristics of cells producing polypeptide hormones (the APUD series) and their relevance to thyroid and ultimobranchial C-cells and calcitonin. Proc Roy Soc (London) 170:71
Polak JM, Bloom SR (1979) The diffuse neuroendocrine system. J Histochem Cytochem 27:1938–1400
Schlaepfer WW, Freeman L (1978) Neurofilament proteins of rat peripheral nerve and spinal cord. J Cell Biol 78:653–662
Schmechel DE, Brightmann MW, Marangos PJ (1980) Neurons switch from non-neuronal enolase to neuron specific enolase during differentiation. Brain Res 190 (1):195–214
Sternberger, LA (1979) Immunocytochemistry. 2nd Ed. Prentice-Hall, New Jersey
Sunderman FW (1974) Measurement of Vanilmandelic acid for the diagnosis of phaeochromocytoma and neuroblastoma. A J Clin Pathol 42:481–497
Tapia FJ, Polak JM, Barbosa AJA, Bloom SR, Marangos PJ, Dermody C, Pearse AGE (1981): Neuron specific enolase is produced by endocrine tumours. Lancet I, 808–811
Thibault J, Vidal D, Gros F (1981) In vitro translation of mRNA from cat phaeochromocytoma tumours, characterisation of tyrosine hydroxylase. Biochem Biophys Res Comm 99 (3):960–968
Wahl HR (1914) Neuroblastoma with study of a case illustrating the 3 types that arise from the sympathetic nervous system. J Med Res 30:205–260
Zelter PM, Marangos PJ, Parma AM, Sather H, Dalton A, Hammon D, Siegel SF, Seeger RC (1983) Raised neuron specific enolase in serum of children in metastatic neuroblastoma. Lancet II:361–363
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carlei, F., Polak, J.M., Ceccamea, A. et al. Neuronal and glial markers in tumours of neuroblastic origin. Vichows Archiv A Pathol Anat 404, 313–324 (1984). https://doi.org/10.1007/BF00694896
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00694896